PBCAR269A

DB17188InvestigationalCell transplant therapies

PBCAR269A: Overview.

Mechanism: Pharmacologically active on Tumor necrosis factor receptor superfamily member 17
Curator reviewed
Also known as: Allogeneic gene edited BCMA-directed CAR T cells
Code names: PBCAR 269A

Resolves to

Targets

What you can answer from here — as of July 08, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

1Clinical trialPhase, status and sponsor resolved per trial

1+ReferenceStructured and connected to the statements they support

Which drugs share a target with PBCAR269A, and which of those have an active Phase 3 trial?

Create a free account or log in to explore the full data card.